Advisornet Financial’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112 | Hold |
206
| – | – | ﹤0.01% | 2145 |
|
|
2025
Q1 | $135 | Hold |
206
| – | – | ﹤0.01% | 2079 |
|
|
2024
Q4 | $210 | Sell |
206
-1,880
| -90% | -$1.92K | ﹤0.01% | 1861 |
|
|
2024
Q3 | $1.81K | Hold |
2,086
| – | – | ﹤0.01% | 1766 |
|
|
2024
Q2 | $747 | Hold |
2,086
| – | – | ﹤0.01% | 1862 |
|
|
2024
Q1 | $1.4K | Hold |
2,086
| – | – | ﹤0.01% | 1671 |
|
|
2023
Q4 | $1.13K | Hold |
2,086
| – | – | ﹤0.01% | 1848 |
|
|
2023
Q3 | $1.25K | Hold |
2,086
| – | – | ﹤0.01% | 1752 |
|
|
2023
Q2 | $2.71K | Hold |
2,086
| – | – | ﹤0.01% | 1647 |
|
|
2023
Q1 | $3.67K | Hold |
2,086
| – | – | ﹤0.01% | 1565 |
|
|
2022
Q4 | $6.55K | Hold |
2,086
| – | – | ﹤0.01% | 1407 |
|
|
2022
Q3 | $10K | Hold |
2,086
| – | – | ﹤0.01% | 1329 |
|
|
2022
Q2 | $9K | Hold |
2,086
| – | – | ﹤0.01% | 1372 |
|
|
2022
Q1 | $12K | Buy |
2,086
+206
| +11% | +$1.19K | ﹤0.01% | 1389 |
|
|
2021
Q4 | $14K | Buy |
+1,880
| New | +$14K | ﹤0.01% | 1388 |
|